Replimune Group, Inc.(REPL) announced the pricing of its public offering of 6.923 million common shares at $13.00 per share. The offering is expected to close on November 27, 2024.
Replimune announced the pricing of public offering of pre-funded warrants to purchase 3.846 million common shares at a purchase price of $12.9999 per pre-funded warrant, which equals public offering price per share of common stock less the $0.0001 per share exercise price of each pre-funded warrant.
In addition, Replimune has granted underwriter a 30-day option to purchase up to an additional 1.615 common shares.
The company expects offering gross proceeds to be about $140 million, before expenses.
Leerink Partners is acting as sole bookrunning manager for the offering.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.